Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Gainers

• Biocept, Inc. (NASDAQ:BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
• Shift Technologies, Inc. (NASDAQ:SFT) shares rose 74.4% to $0.1878 in pre-market trading. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
• Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares gained 45% to $2.45 in pre-market trading after gaining around 4% on Tuesday.
• RVL Pharmaceuticals plc (NASDAQ:RVLP) shares climbed 41.2% to $0.0720 in pre-market trading after falling 12% on Tuesday. RVL Pharmaceuticals said on Oct. 12, the company received a delisting notice from the Listing Qualifications Department of Nasdaq Stock Market LLC.
• Intelligent Bio Solutions Inc. (NASDAQ:INBS) rose 28.6% to $0.3912 in pre-market trading.
• Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) shares rose 14.4% to $0.3498 in pre-market trading after jumping 15% on Tuesday.
• Advent Technologies Holdings, Inc. (NASDAQ:ADN) gained 14.3% to $0.4799 in pre-market trading.
• Micromobility.com Inc. (NASDAQ:MCOM) shares rose 12.8% to $0.0466 in pre-market trading after surging 15% on Tuesday.
• Viking Therapeutics, Inc. (NASDAQ:VKTX) rose 11.4% to $11.95 in pre-market trading. Viking Therapeutics presented new data from the Phase 1 clinical trial of dual GLP-1/GIP receptor agonist VK2735 in an oral presentation at ObesityWeek 2023.
• Talaris Therapeutics, Inc. (NASDAQ:TALS) shares jumped 8.2% to $3.05 in pre-market trading after the company reported stockholder approval of merger with Tourmaline Bio and announced a 1-for-10 reverse stock split of common stock.

Losers

• NuZee, Inc. (NASDAQ:NUZE) dipped 30.8% to $3.60 in pre-market trading after announcing a proposed public offering of common stock.
• Nuvve Holding Corp. (NASDAQ:NVVE) shares fell 13.4% to $0.2270 in pre-market trading after dipping 33% on Tuesday.
• SciSparc Ltd. (NASDAQ:SPRC) shares fell 12.5% to $5.52 in pre-market trading, after jumping 123% on Tuesday. The company recently announced the closing of a $5 million private placement and regained compliance with the Nasdaq minimum bid price rule.
• Notable Labs, Inc. (NASDAQ:NTBL) fell 12.5% to $3.93 in pre-market. JMP Securities initiated coverage on Notable Labs with a Market Outperform rating and announced a price target of $13.
• BIO-key International, Inc. (NASDAQ:BKYI) shares fell 11.5% to $0.3022 in pre-market trading after declining 34% on Tuesday. BIO-Key International filed for an offering of units of up to $10 million.
• Ucommune International Ltd (NASDAQ:UK) shares fell 9.1% to $0.3090 in pre-market trading after declining 8% on Tuesday. Ucommune International said that an extraordinary general meeting of the Company will be held on Nov. 29, 2023.
• China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares fell 8.5% to $2.92 in pre-market trading after gaining over 10% on Tuesday. China SXT Pharmaceuticals recently announced a 1-for-25 reverse stock split.
• Blue Star Foods Corp. (NASDAQ:BSFC) shares fell 6.8% to $0.1842 in pre-market trading, after gaining over 8% on Tuesday.
• Bio-Path Holdings, Inc. (NASDAQ:BPTH) fell 6.5% to $0.5802 in pre-market trading after declining around 9% on Tuesday.
• Tempest Therapeutics, Inc. (NASDAQ:TPST) fell 5.6% to $6.77 in pre-market trading. Last Wednesday, TPST shares soared nearly 4000% after the company announced results from its ongoing Phase 1B/2 study of the company's TPST-1120 combination, which showed clinical superiority to existing treatments.

Now Read This: Fear & Greed Index Remains In 'Fear' Zone As Investors Assess Earnings Reports